首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia.
【24h】

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia.

机译:microRNA的异常过表达通过自然杀伤细胞淋巴瘤/白血病中肿瘤抑制因子的下调激活AKT信号传导。

获取原文
获取原文并翻译 | 示例
           

摘要

The gene(s) responsible for natural killer (NK)-cell lymphoma/leukemia have not been identified. In the present study, we found that in NK-cell lymphoma lines (n = 10) and specimens of primary lymphoma (n = 10), levels of miR-21 and miR-155 expression were inversely related and were significantly greater than those found in normal natural killer (CD3(-)CD56(+)) cells (n = 8). To determine the functions of these microRNAs in lymphomagenesis, we examined the effects of antisense oligonucleotides (ASOs) targeting miR-21 (ASO-21) and/or miR-155 (ASO-155) in NK-cell lymphoma lines overexpressing one or both of these miRNAs. Conversely, cells showing little endogenous expression of miR-21 or miR-155 were transduced by the use of lentiviral vectors, leading to their overexpression. Reducing expression of miR-21 or miR-155 led to up-regulation of phosphatase and tensin homologue (PTEN), programmed cell death 4 (PDCD4), or Src homology-2 domain-containing inositol 5-phosphatase 1 (SHIP1). ASO-21- and ASO-155-treated cell lines all showed down-regulation of phosphorylated AKT(ser473). Moreover, transduction with either miR-21 or miR-155 led to down-regulation of PTEN and PDCD4 or SHIP1 with up-regulation of phosphorylated AKT(ser473). Collectively, these results provide important new insight into the pathogenesis of NK-cell lymphoma/leukemia and suggest targeting miR-21 and/or miR-155 may represent a useful approach to treating NK-cell lymphoma/leukemia.
机译:尚未发现负责自然杀手(NK)细胞淋巴瘤/白血病的基因。在本研究中,我们发现在NK细胞淋巴瘤系(n = 10)和原发性淋巴瘤标本(n = 10)中,miR-21和miR-155表达水平呈负相关,并且显着高于所发现的水平。在正常的自然杀手(CD3(-)CD56(+))细胞中(n = 8)。为了确定这些microRNA在淋巴瘤发生中的功能,我们检查了针对miR-21(ASO-21)和/或miR-155(ASO-155)的反义寡核苷酸(ASOs)在过表达一种或两种细胞的NK细胞淋巴瘤中的作用这些miRNA。相反,通过使用慢病毒载体转导几乎没有内源性表达miR-21或miR-155的细胞,导致其过表达。减少miR-21或miR-155的表达导致磷酸酶和张力蛋白同源物(PTEN)上调,程序性细胞死亡4(PDCD4)或含有Src同源性2结构域的肌醇5-磷酸酶1(SHIP1)。 ASO-21和ASO-155处理的细胞系均显示出磷酸化AKT(ser473)的下调。此外,miR-21或miR-155的转导导致PTEN和PDCD4或SHIP1的下调,而磷酸化AKT(ser473)的上调。总体而言,这些结果为NK细胞淋巴瘤/白血病的发病机理提供了重要的新见解,并提示靶向miR-21和/或miR-155可能代表治疗NK细胞淋巴瘤/白血病的有用方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号